NFE2L2 and cancer: Hence, the Keap1/Nrf2/xCT signaling pathway, a master regulator of cysteine metabolism, is frequently mutated in cancers and can be activated by oncogenic drivers such as KRas and PI3K, underscoring its critical role in tumorigenesis (127).